dr. arteaga on molecular profiling in triple-negative breast cancer
Published 11 years ago • 148 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
1:34
dr. arteaga on the results and impact of the follow-up of the neoaltto trial
-
1:00
dr. arteaga discusses the calgb 40603 trial
-
2:10
testing and targeted therapy in triple negative breast cancer: 2023 west oncology
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
22:54
testing, treating, and targeting triple negative breast cancer | 2023 west oncology conference
-
3:50
clinical approach to triple-negative breast cancer
-
3:18
justin balko on activations in the jak-stat pathway in triple-negative breast cancer
-
1:34
dr. arteaga on ongoing trials in metastatic breast cancer
-
8:22
molecular profiling in early breast cancer
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
45:48
triple negative breast cancer
-
1:17
recognizing subsets of triple-negative breast cancer
-
1:01
dr. page on hormone-directed strategies in triple-negative breast cancer
-
3:26
comparing 126 tnbc mpbc tumors at caris life sciences
-
5:15
decode heterogeneity with the breast cancer 360 panel
-
2:39
biomarker-driven therapies for triple-negative breast cancer
-
2:43
choosing treatment regimens in patients with triple-negative breast cancer
-
1:58:32
overcoming the big obstacles to find solutions for breast cancer | dr. carlos arteaga | sabcs 2022